{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:23:39Z","timestamp":1793309019093,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116850","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T08:54:10Z","timestamp":1725612850000},"page":"116850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Anticancer potential of active alkaloids and synthetic analogs derived from marine invertebrates"],"prefix":"10.1016","volume":"279","author":[{"given":"Chunyan","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-849X","authenticated-orcid":false,"given":"Xiaofang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116850_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2024.116850_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2024.116850_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3322\/caac.21443","article-title":"The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment: a Primer on Financial Toxicity","volume":"68","author":"Carrera","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2024.116850_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2020.01.011","article-title":"The cost of cancer in Europe 2018","volume":"129","author":"Hofmarcher","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejmech.2024.116850_bib5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/09553002.2021.1919782","article-title":"Preliminary pre-clinical studies on the side effects of breast cancer treatment","volume":"97","author":"Salata","year":"2021","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.ejmech.2024.116850_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11864-020-00812-1","article-title":"Metabolic aspects of Anthracycline cardiotoxicity","volume":"22","author":"Russo","year":"2021","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.ejmech.2024.116850_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172472","article-title":"Alkaloids for cancer prevention and therapy: current progress and future perspectives","volume":"858","author":"Mondal","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116850_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/md20100605","article-title":"The sponge-derived brominated compound aeroplysinin-1 impairs the endothelial inflammatory response through inhibition of the NF-\u03baB pathway","volume":"20","author":"Vidal","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3390\/md20110693","article-title":"Anti-inflammatory effects of compounds from echinoderms","volume":"20","author":"Ghelani","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/md19110632","article-title":"Unravelling the anti-inflammatory and antioxidant potential of the marine sponge cliona celata from the Portuguese coastline","volume":"19","author":"Alves","year":"2021","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/md16080289","article-title":"Chromone derivatives and other constituents from cultures of the marine sponge-associated fungus Penicillium erubescens KUFA0220 and their antibacterial activity","volume":"16","author":"Kumla","year":"2018","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3390\/md18120619","article-title":"Marine anticancer agents: an overview with a particular focus on their chemical classes","volume":"18","author":"Barreca","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/md17080474","article-title":"The anticancer drug discovery potential of marine invertebrates from Russian pacific","volume":"17","author":"Katanaev","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.lfs.2005.09.007","article-title":"Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases","volume":"78","author":"Gul","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2024.116850_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.909566","article-title":"From seaside to bedside: current evidence and future perspectives in the treatment of breast cancer using marine compounds","volume":"13","author":"De Sanctis","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116850_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/md20040219","article-title":"Biomaterials and bioactive natural products from marine invertebrates: from basic research to innovative applications","volume":"20","author":"Romano","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175330","article-title":"Potential role of Marine Bioactive Compounds in cancer signaling pathways: a review","volume":"936","author":"Manoharan","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116850_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129102","article-title":"A concise review on marine bromopyrrole alkaloids as anticancer agents","volume":"80","author":"Mahamed","year":"2023","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116850_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/md17060329","article-title":"Marine-derived anticancer agents: clinical benefits, innovative mechanisms, and new targets","volume":"17","author":"Pereira","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib20","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s40265-020-01374-0","article-title":"Lurbinectedin: first approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S2213-2600(22)00309-5","article-title":"Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial","volume":"11","author":"Aix","year":"2023","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116850_bib22","article-title":"Breast cancer treatment","volume":"321","author":"Waks","year":"2019","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejmech.2024.116850_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejmech.2024.116850_bib24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.116850_bib25","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1245\/s10434-022-12190-z","article-title":"Impact of locoregional treatment on survival in young patients with early-stage breast cancer undergoing upfront surgery","volume":"29","author":"Orozco","year":"2022","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.ejmech.2024.116850_bib26","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/jama.2017.12890","article-title":"Breast cancer surgery: less is more","volume":"318","author":"Livingston","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2024.116850_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40265-019-01227-5","article-title":"Treating persistent pain after breast cancer surgery","volume":"80","author":"Khan","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib28","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/jnci\/djz105","article-title":"A network meta-analysis of surgical treatment in patients with early breast cancer","volume":"111","author":"Gui","year":"2019","journal-title":"J. Natl. Cancer Inst.: J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2024.116850_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10549-020-05641-2","article-title":"Carbon ion radiation therapy in breast cancer: a new frontier","volume":"181","author":"Malouff","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejmech.2024.116850_bib30","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ijrobp.2015.12.361","article-title":"Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis","volume":"94","author":"Datta","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejmech.2024.116850_bib31","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.biopha.2018.02.108","article-title":"Chemotherapeutic agents for the treatment of metastatic breast cancer: an update","volume":"101","author":"Abotaleb","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116850_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrc.2017.55","article-title":"Keeping breast cancer in check","volume":"17","author":"Lieben","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2024.116850_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1158\/2159-8290.CD-NB2017-176","volume":"8","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2024.116850_bib34","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1245\/s10434-018-6620-5","article-title":"Immunotherapy for breast cancer is finally at the doorstep: immunotherapy in breast cancer","volume":"25","author":"De La Cruz","year":"2018","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.ejmech.2024.116850_bib35","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/jamaoncol.2016.3631","article-title":"Optimizing adjuvant chemotherapy and surgery for early- and late-stage breast cancer","volume":"2","author":"Vaz-Luis","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ejmech.2024.116850_bib36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijrobp.2017.05.029","article-title":"Combined radiation therapy and immune checkpoint blockade therapy for breast cancer","volume":"99","author":"Hu","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejmech.2024.116850_bib37","doi-asserted-by":"crossref","first-page":"l4727","DOI":"10.1136\/bmj.l4727","article-title":"Breast cancer: NICE approves new drug combination treatment","author":"Mahase","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ejmech.2024.116850_bib38","first-page":"22","article-title":"New drugs for breast cancer","volume":"120","author":"Aschenbrenner","year":"2020","journal-title":"AJN, American Journal of Nursing"},{"key":"10.1016\/j.ejmech.2024.116850_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108296","article-title":"Advances in Trop 2-targeted therapy: novel agents and opportunities beyond breast cancer","volume":"239","author":"Liu","year":"2022","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2024.116850_bib40","first-page":"23","article-title":"New drug for late- stage breast cancer","volume":"113","author":"Aschenbrenner","year":"2013","journal-title":"AJN, American Journal of Nursing"},{"key":"10.1016\/j.ejmech.2024.116850_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114165","article-title":"Marine life as a source for breast cancer treatment: a comprehensive review","volume":"159","author":"Hussain","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116850_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cbi.2017.07.017","article-title":"A marine sponge alkaloid derivative 4-chloro fascaplysin inhibits tumor growth and VEGF mediated angiogenesis by disrupting PI3K\/Akt\/mTOR signaling cascade","volume":"275","author":"Sharma","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2024.116850_bib43","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1248\/cpb.37.1676","article-title":"G, H, and J, new vasodilative bis-1-oxaquinolizidine alkaloids from an Okinawan marine sponge, Xestospongia sp","volume":"37","author":"Kobayashi","year":"1989","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2024.116850_bib44","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1021\/np0202226","article-title":"New Bioactive Bis-1-oxaquinolizidine N -Oxide Alkaloids from Red Sea Specimens of Xestospongia e xigua","volume":"65","author":"Orabi","year":"2002","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116850_bib45","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/md13010288","article-title":"Araguspongine c induces autophagic death in breast cancer cells through suppression of c-met and her2 receptor tyrosine kinase signaling","volume":"13","author":"Akl","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib46","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.3390\/md11114419","article-title":"Crambescidin-816 acts as a fungicidal with more potency than crambescidin-800 and -830, inducing cell cycle arrest, increased cell size and apoptosis in Saccharomyces cerevisiae","volume":"11","author":"Rubiolo","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/md16020053","article-title":"Crambescidin 800, isolated from the marine sponge Monanchora viridis, induces cell cycle arrest and apoptosis in triple-negative breast cancer cells","volume":"16","author":"Shrestha","year":"2018","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib48","doi-asserted-by":"crossref","first-page":"83071","DOI":"10.18632\/oncotarget.13068","article-title":"Marine guanidine alkaloids crambescidins inhibit tumor growth and activate intrinsic apoptotic signaling inducing tumor regression in a colorectal carcinoma zebrafish xenograft model","volume":"7","author":"Roel","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2024.116850_bib49","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/np50097a004","article-title":"Polycyclic guanidine alkaloids from the marine sponge Crambe crambe and Ca ++ channel blocker activity of crambescidin 816","volume":"56","author":"Berlinck","year":"1993","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116850_bib50","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41419-021-03680-1","article-title":"Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637\/Akt1\/\u03b2-catenin (cyclin D1) axis","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2024.116850_bib51","doi-asserted-by":"crossref","first-page":"11395","DOI":"10.1021\/acs.jmedchem.1c00734","article-title":"Amphipathic barbiturates as mimics of antimicrobial peptides and the marine natural products eusynstyelamides with activity against multi-resistant clinical isolates","volume":"64","author":"Paulsen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116850_bib52","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.3390\/md12105222","article-title":"Identification of eusynstyelamide B as a potent cell cycle inhibitor following the generation and screening of an ascidian-derived extract library using a real time cell analyzer","volume":"12","author":"Liberio","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib53","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/np900099j","article-title":"Eusynstyelamides A, B, and C, nNOS inhibitors, from the ascidian Eusynstyela latericius","volume":"72","author":"Tapiolas","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116850_bib54","doi-asserted-by":"crossref","first-page":"43944","DOI":"10.18632\/oncotarget.6267","article-title":"The ascidian natural product eusynstyelamide B is a novel topoisomerase II poison that induces DNA damage and growth arrest in prostate and breast cancer cells","volume":"6","author":"Liberio","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2024.116850_bib55","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.3390\/md12126003","article-title":"Aaptamine derivatives with antifungal and anti-HIV-1 activities from the south China sea sponge aaptos aaptos","volume":"12","author":"Yu","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib56","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1080\/13880209.2022.2102657","article-title":"Aaptamine \u2013 a dual acetyl \u2013 and butyrylcholinesterase inhibitor as potential anti-Alzheimer\u2019s disease agent","volume":"60","author":"Miao","year":"2022","journal-title":"Pharmaceut. Biol."},{"key":"10.1016\/j.ejmech.2024.116850_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114359","article-title":"Isoaaptamine increases ROS levels causing autophagy and mitochondria-mediated apoptosis in glioblastoma multiforme cells","volume":"160","author":"Wen","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116850_bib58","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1080\/13880209.2020.1822420","article-title":"Aaptamine attenuates the proliferation and progression of non-small cell lung carcinoma","volume":"58","author":"Gong","year":"2020","journal-title":"Pharmaceut. Biol."},{"key":"10.1016\/j.ejmech.2024.116850_bib59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1021\/acs.jnatprod.2c00673","article-title":"Marine sponge-derived alkaloid induces mitochondrial dysfunction and inhibits the PI3K\/AKT\/mTOR signaling pathway against burkitt's lymphoma","volume":"86","author":"Zhao","year":"2023","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116850_bib60","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1021\/np500583z","article-title":"Cytotoxic aaptamine derivatives from the south China sea sponge Aaptos aaptos","volume":"77","author":"Yu","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116850_bib61","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/md16010018","article-title":"Isoaaptamine induces T-47d cells apoptosis and autophagy via oxidative stress","volume":"16","author":"Wu","year":"2018","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib62","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1021\/ja00280a055","article-title":"Manzamine A, a novel antitumor alkaloid from a sponge","volume":"108","author":"Sakai","year":"1986","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116850_bib63","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1021\/np9604083","article-title":"Four new bioactive manzamine-type alkaloids from the philippine marine sponge Xestospongia ashmorica","volume":"59","author":"Edrada","year":"1996","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116850_bib64","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.3390\/md11093500","article-title":"The marine natural product manzamine A targets vacuolar ATPases and inhibits autophagy in pancreatic cancer cells","volume":"11","author":"Kallifatidis","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib65","unstructured":"Y.-J. Lin, C.-Y. Huang, Y.-C. Shen, K.-C. Wei, C.-C. Chuang, P.-W. Hsu, Y.-C. Huang, T.-L. Hwang, P.-Y. Chen, A Manzamine-Derived Compound as a Potential Therapeutic Agent for Glioma by Inducing Apoptosis and Cell Cycle Arrest, (n.d.) 14."},{"key":"10.1016\/j.ejmech.2024.116850_bib66","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/s41598-019-38590-y","article-title":"Macrophage migration inhibitory factor acts as the potential target of a newly synthesized compound, 1-(9\u2032-methyl-3\u2032-carbazole)-3, 4-dihydro-\u03b2-carboline","volume":"9","author":"Ko","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116850_bib67","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0006-2952(91)90031-Y","article-title":"Antitumor activity and biochemical effects of topsentin","volume":"42","author":"Burres","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116850_bib68","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/md18040190","article-title":"Marine-Inspired bis-indoles possessing antiproliferative activity against breast cancer; design, synthesis, and biological evaluation","volume":"18","author":"Eldehna","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib69","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejmech.2017.06.052","article-title":"Synthesis, antitumor activity and CDK1 inhibiton of new thiazole nortopsentin analogues","volume":"138","author":"Parrino","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116850_bib70","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.116850_bib71","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1056\/NEJMe1814034","article-title":"Surgery in cervical cancer","volume":"379","author":"Fader","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2024.116850_bib72","first-page":"S593","article-title":"Radiotherapy and treatment of cervical cancer \u2013 sexuality implications","volume":"33","author":"Fornelos","year":"2016","journal-title":"Eur. Psychiatr."},{"key":"10.1016\/j.ejmech.2024.116850_bib73","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1016\/j.ijrobp.2018.07.1697","article-title":"Improvement in patient-reported distress after chemo-radiation in cervical cancer patients","volume":"102","author":"Conway","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejmech.2024.116850_bib74","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11912-021-01052-8","article-title":"Immunotherapy in cervical cancer","volume":"23","author":"Mauricio","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.ejmech.2024.116850_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102088","article-title":"Immunotherapy in cervix cancer","volume":"90","author":"Attademo","year":"2020","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.ejmech.2024.116850_bib76","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijrobp.2020.09.016","article-title":"Current status of clinical trials for cervical and uterine cancer using immunotherapy combined with radiation","volume":"109","author":"Dyer","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejmech.2024.116850_bib77","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer","volume":"543","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116850_bib78","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/14712598.2019.1646721","article-title":"Pembrolizumab for the treatment of cervical cancer","volume":"19","author":"Marret","year":"2019","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.ejmech.2024.116850_bib79","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2018-000462","article-title":"Targeted therapy in cervical cancer","volume":"3","author":"Vora","year":"2018","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejmech.2024.116850_bib80","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1021\/acs.jnatprod.9b00577","article-title":"The marine natural product manzamine A inhibits cervical cancer by targeting the SIX1 protein","volume":"83","author":"Karan","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116850_bib81","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/ijc.28755","article-title":"Six1: a critical transcription factor in tumorigenesis: functional roles of Six1","volume":"136","author":"Wu","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2024.116850_bib82","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ccell.2018.01.010","article-title":"Transcriptional regulation of the warburg effect in cancer by SIX1","volume":"33","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2024.116850_bib83","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3390\/md19090506","article-title":"RSK1 vs. RSK2 inhibitory activity of the marine \u03b2-carboline alkaloid manzamine A: a biochemical, cervical cancer protein expression, and computational study","volume":"19","author":"Mayer","year":"2021","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib84","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.trecan.2017.03.004","article-title":"Selective targeting of RSK isoforms in cancer","volume":"3","author":"Casalvieri","year":"2017","journal-title":"Trends in Cancer"},{"key":"10.1016\/j.ejmech.2024.116850_bib85","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nrm2509","article-title":"The RSK family of kinases: emerging roles in cellular signalling","volume":"9","author":"Anjum","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.116850_bib86","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejmech.2013.02.032","article-title":"4-Amino-2-arylamino-5-indoloyl\/cinnamoythiazoles, analogs of topsentin-class of marine alkaloids, induce apoptosis in HeLa cells","volume":"63","author":"Juneja","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116850_bib87","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway","volume":"296","author":"Chen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116850_bib88","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.3390\/cancers14174254","article-title":"Colorectal cancer in inflammatory bowel diseases: epidemiology and prevention: a review","volume":"14","author":"Marabotto","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2024.116850_bib89","doi-asserted-by":"crossref","first-page":"hcab103","DOI":"10.1093\/qjmed\/hcab103","article-title":"Retrospective analysis of epidemiology, prognostic factors and response of treatment of rectal cancer","volume":"114","author":"El Wakiel","year":"2021","journal-title":"QJM: Int. J. Med."},{"key":"10.1016\/j.ejmech.2024.116850_bib90","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.3390\/cancers15133381","article-title":"Influence of laparoscopic surgery on cellular immunity in colorectal cancer: a systematic review and meta-analysis","volume":"15","author":"Bohne","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2024.116850_bib91","article-title":"Homologous recombination pathway alternation predicts prognosis of colorectal cancer with chemotherapy","volume":"13","author":"Lin","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116850_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1105180","article-title":"Radioimmunotherapy in colorectal cancer treatment: present and future","volume":"14","author":"Shi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2024.116850_bib93","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","article-title":"Wnt signaling in colorectal cancer: pathogenic role and therapeutic target","volume":"21","author":"Zhao","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2024.116850_bib94","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13046-018-0753-z","article-title":"The phospholipase DDHD1 as a new target in colorectal cancer therapy","volume":"37","author":"Raimondo","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2024.116850_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103681","article-title":"The HER family as therapeutic targets in colorectal cancer","volume":"174","author":"Ye","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ejmech.2024.116850_bib96","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2024.116850_bib97","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/cancers13051047","article-title":"HER2-\/HER3-Targeting antibody\u2014drug conjugates for treating lung and colorectal cancers resistant to EGFR inhibitors","volume":"13","author":"Yonesaka","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2024.116850_bib98","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/gutjnl-2020-323553","article-title":"PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells","volume":"71","author":"Mangiapane","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ejmech.2024.116850_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/md14010001","article-title":"Aeroplysinin-1, a sponge-derived multi-targeted bioactive marine drug","volume":"14","author":"Garc\u00eda-Vilas","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110566","article-title":"Marine biomaterials: biomimetic and pharmacological potential of cultivated Aplysina aerophoba marine demosponge","volume":"109","author":"Binnewerg","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejmech.2024.116850_bib101","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.3390\/md10092033","article-title":"The antiangiogenic compound aeroplysinin-1 induces apoptosis in endothelial cells by activating the mitochondrial pathway","volume":"10","author":"Mart\u00ednez-Poveda","year":"2012","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib102","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.fct.2016.04.019","article-title":"Cytotoxic activity of aeroplysinin-1 against colon cancer cells by promoting \u03b2-catenin degradation","volume":"93","author":"Park","year":"2016","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2024.116850_bib103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/md14040077","article-title":"Polycyclic guanidine alkaloids from poecilosclerida marine sponges","volume":"14","author":"Sfecci","year":"2016","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib104","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1021\/acs.jnatprod.6b00168","article-title":"Cytotoxic guanidine alkaloids from a French polynesian Monanchora n. sp. sponge","volume":"79","author":"El-Demerdash","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116850_bib105","doi-asserted-by":"crossref","first-page":"83071","DOI":"10.18632\/oncotarget.13068","article-title":"Marine guanidine alkaloids crambescidins inhibit tumor growth and activate intrinsic apoptotic signaling inducing tumor regression in a colorectal carcinoma zebrafish xenograft model","volume":"7","author":"Roel","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2024.116850_bib106","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrc1126","article-title":"Cancer genetics and drug discovery in the zebrafish","volume":"3","author":"Stern","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2024.116850_bib107","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3324\/haematol.2010.031401","article-title":"Leukemic cell xenograft in zebrafish embryo for investigating drug efficacy","volume":"96","author":"Pruvot","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.ejmech.2024.116850_bib108","doi-asserted-by":"crossref","first-page":"12965","DOI":"10.1073\/pnas.97.24.12965","article-title":"Small molecule developmental screens reveal the logic and timing of vertebrate development","volume":"97","author":"Peterson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2024.116850_bib109","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/bjc.1996.421","article-title":"Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein","volume":"74","author":"Quesada","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2024.116850_bib110","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1021\/bc800503k","article-title":"Lamellarin D bioconjugates I: synthesis and cellular internalization of PEG-derivatives","volume":"20","author":"Pla","year":"2009","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejmech.2024.116850_bib111","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2009.09.017","article-title":"Novel hybrids from lamellarin D and combretastatin A 4 as cytotoxic agents","volume":"45","author":"Shen","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116850_bib112","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1039\/c2ob06747a","article-title":"A search for BACE inhibitors reveals new biosynthetically related pyrrolidones, furanones and pyrroles from a southern Australian marine sponge, Ianthella sp","volume":"10","author":"Zhang","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2024.116850_bib113","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/asia.201101049","article-title":"Lamellarins as inhibitors of P\u2010Glycoprotein\u2010Mediated multidrug resistance in a human colon cancer cell line","volume":"7","author":"Plisson","year":"2012","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.ejmech.2024.116850_bib114","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.3390\/md12073818","article-title":"A pyrrole alkaloid from an Australian marine sponge, ianthella sp., reverses BCRP mediated drug resistance in cancer cells","volume":"12","author":"Huang","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib115","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/1535-7163.MCT-09-0639","article-title":"Essential role of mitochondria in apoptosis of cancer cells induced by the marine alkaloid Lamellarin D","volume":"8","author":"Ballot","year":"2009","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2024.116850_bib116","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10495-010-0471-2","article-title":"Inhibition of mitochondrial respiration mediates apoptosis induced by the anti-tumoral alkaloid lamellarin D","volume":"15","author":"Ballot","year":"2010","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2024.116850_bib117","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1158\/0008-5472.CAN-05-1929","article-title":"Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin D","volume":"66","author":"Kluza","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2024.116850_bib118","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/md20080026","article-title":"Anticancer alkaloid lamellarins inhibit protein kinases","volume":"6","author":"Baunb\u00e6k","year":"2008","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib119","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/md12020779","article-title":"Another facet to the anticancer response to lamellarin D: induction of cellular senescence through inhibition of topoisomerase I and intracellular ros production","volume":"12","author":"Ballot","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/mol.114.092833","article-title":"Poisoning of mitochondrial topoisomerase I by lamellarin D","volume":"86","author":"Khiati","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116850_bib121","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bmc.2018.11.037","article-title":"Lamellarin-inspired potent topoisomerase I inhibitors with the unprecedented benzo[g][1]benzopyrano[4,3-b]indol-6(13H)-one scaffold","volume":"27","author":"Fukuda","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116850_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113226","article-title":"Design, synthesis and structure-activity relationship studies of glycosylated derivatives of marine natural product lamellarin D","volume":"214","author":"Zheng","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116850_bib123","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.3390\/md12094833","article-title":"An improved high yield total synthesis and cytotoxicity study of the marine alkaloid neoamphimedine: an ATP-competitive inhibitor of topoisomerase II\u03b1 and potent anticancer agent","volume":"12","author":"Li","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib124","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1038\/onc.2016.29","article-title":"Topoisomerase II\u03b1 mediates TCF-dependent epithelial\u2013mesenchymal transition in colon cancer","volume":"35","author":"Zhou","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2024.116850_bib125","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0006-2952(03)00209-0","article-title":"The anti-neoplastic and novel topoisomerase II-mediated cytotoxicity of neoamphimedine, a marine pyridoacridine","volume":"66","author":"Marshall","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116850_bib126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41572-021-00249-2","volume":"7","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejmech.2024.116850_bib127","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2967\/jnumed.121.262997","article-title":"The history of prostate-specific membrane antigen as a theranostic target in prostate cancer: the cornerstone role of the prostate cancer foundation","volume":"63","author":"Miyahira","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2024.116850_bib128","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41388-023-02597-7","article-title":"CXCR7 as a novel therapeutic target for advanced prostate cancer","volume":"42","author":"Gritsina","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2024.116850_bib129","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/life12050687","article-title":"The antileukemic and anti-prostatic effect of aeroplysinin-1 is mediated through ROS-induced apoptosis via NOX activation and inhibition of HIF-1a activity","volume":"12","author":"Shih","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.ejmech.2024.116850_bib130","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2174\/138955712800626719","article-title":"Chemistry and biology of fascaplysin, a potent marine-derived CDK-4 inhibitor","volume":"12","author":"Bharate","year":"2012","journal-title":"MRMC"},{"key":"10.1016\/j.ejmech.2024.116850_bib131","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejmech.2019.01.011","article-title":"Cink4T, a quinazolinone-based dual inhibitor of Cdk4 and tubulin polymerization, identified via ligand-based virtual screening, for efficient anticancer therapy","volume":"165","author":"Sonawane","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116850_bib132","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3390\/md17090496","article-title":"Ermakova, grigorchuk, Kaune, Amsberg, Dyshlovoy, total syntheses and preliminary biological evaluation of brominated fascaplysin and reticulatine alkaloids and their analogues","volume":"17","author":"Zhidkov","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib133","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/md18120609","article-title":"Efficacy and mechanism of action of marine alkaloid 3,10-dibromofascaplysin in drug-resistant prostate cancer cells","volume":"18","author":"Dyshlovoy","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib134","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1080\/14786419.2017.1419231","article-title":"Monanchoxymycalin C with anticancer properties, new analogue of crambescidin 800 from the marine sponge Monanchora pulchra","volume":"33","author":"Shubina","year":"2019","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2024.116850_bib135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69751-z","article-title":"Marine alkaloid monanchoxymycalin C: a new specific activator of JNK1\/2 kinase with anticancer properties","volume":"10","author":"Dyshlovoy","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116850_bib136","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/md14070133","article-title":"Guanidine alkaloids from the marine sponge Monanchora pulchra show cytotoxic properties and prevent EGF-induced neoplastic transformation in vitro","volume":"14","author":"Dyshlovoy","year":"2016","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib137","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1038\/s41598-020-66428-5","article-title":"Urupocidin C: a new marine guanidine alkaloid which selectively kills prostate cancer cells via mitochondria targeting","volume":"10","author":"Dyshlovoy","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116850_bib138","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.116850_bib139","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cancers12040875","article-title":"Structure\u2013activity relationships and molecular docking analysis of Mcl-1 targeting renieramycin T analogues in Patient-derived lung cancer cells","volume":"12","author":"Petsri","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2024.116850_bib140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/md20040235","article-title":"5-O-(N-Boc-l-Alanine)-Renieramycin T induces cancer stem cell apoptosis via targeting Akt signaling","volume":"20","author":"Suksamai","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib141","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1021\/np030262p","article-title":"Chemistry of renieramycins. Part 3. Isolation and structure of stabilized renieramycin type derivatives possessing antitumor activity from Thai sponge Xestospongia species, pretreated with potassium cyanide","volume":"66","author":"Suwanborirux","year":"2003","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116850_bib142","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1021\/np400277m","article-title":"Replacement of a quinone by a 5- O -acetylhydroquinone abolishes the accidental necrosis inducing effect while preserving the apoptosis-inducing effect of renieramycin M on lung cancer cells","volume":"76","author":"Cheun-Arom","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116850_bib143","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1021\/acs.jnatprod.7b00068","article-title":"Chemistry of renieramycins. 17. A new generation of renieramycins: hydroquinone 5- O -monoester analogues of renieramycin M as potential cytotoxic agents against non-small-cell lung cancer cells","volume":"80","author":"Chamni","year":"2017","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116850_bib144","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/ph14111112","article-title":"Hydroquinone 5-O-cinnamoyl ester of renieramycin M suppresses lung cancer stem cells by targeting Akt and destabilizes c-Myc","volume":"14","author":"Hongwiangchan","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2024.116850_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103756","article-title":"Therapeutic targeting of \u201cundruggable\u201d MYC","volume":"75","author":"Llombart","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2024.116850_bib146","doi-asserted-by":"crossref","first-page":"a014365","DOI":"10.1101\/cshperspect.a014365","article-title":"MYC degradation","volume":"4","author":"Farrell","year":"2014","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/j.ejmech.2024.116850_bib147","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1021\/acs.jnatprod.6b00433","article-title":"Chemistry of renieramycins. 15. Synthesis of 22- O -ester derivatives of jorunnamycin A and their cytotoxicity against non-small-cell lung cancer cells","volume":"79","author":"Sirimangkalakitti","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116850_bib148","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/md18080418","article-title":"Chemistry of renieramycins. Part 19: semi-syntheses of 22-O-amino ester and hydroquinone 5-O-amino ester derivatives of renieramycin M and their cytotoxicity against non-small-cell lung cancer cell lines","volume":"18","author":"Chamni","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib149","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41419-020-2509-x","article-title":"Oncogenic driver genes and tumor microenvironment determine the type of liver cancer","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2024.116850_bib150","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/bph.12552","article-title":"Mechanism of cytotoxic action of crambescidin-816 on human liver-derived tumour cells: effect of crambescidin-816 on tumour cells","volume":"171","author":"Rubiolo","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116850_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/469309","article-title":"Aaptamines from the marine sponge aaptos sp. display anticancer activities in human cancer cell lines and modulate AP-1-, NF- \u03ba B-, and p53-dependent transcriptional activity in mouse JB6 Cl41 cells","volume":"2014","author":"Dyshlovoy","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2024.116850_bib152","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jprot.2013.11.009","article-title":"Activity of aaptamine and two derivatives, demethyloxyaaptamine and isoaaptamine, in cisplatin-resistant germ cell cancer","volume":"96","author":"Dyshlovoy","year":"2014","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.ejmech.2024.116850_bib153","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.3390\/md10092033","article-title":"The antiangiogenic compound aeroplysinin-1 induces apoptosis in endothelial cells by activating the mitochondrial pathway","volume":"10","author":"Mart\u00ednez-Poveda","year":"2012","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116850_bib154","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/md17050301","article-title":"Renieramycin T induces lung cancer cell apoptosis by targeting Mcl-1 degradation: a new Insight in the mechanism of action","volume":"17","author":"Petsri","year":"2019","journal-title":"Mar. Drugs"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424007311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424007311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T15:40:14Z","timestamp":1731253214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424007311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":154,"alternative-id":["S0223523424007311"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116850","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticancer potential of active alkaloids and synthetic analogs derived from marine invertebrates","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116850"}}